Tirzepatide TR5 TR10 TR15 TR20 TR30 TR40 TR50 TR60 CAS2023788-19-2 Customized peptides
TDS 2101 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
shenzhen
sc
2mg/5mg/10mg/15mg/20mg/30mg/40mg/50mg/60mg. 10 bottles per box
Yes
2027-12-31
tr
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History2101 Inquiries
Country Product Purchase Quantity Date Posted
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
Tirzepatide
20 MG Oct 19, 2026
United States
Tirzepatide
300 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
MOTS-c SLU-PP-322 Epithalon 2S10 2S50 MT1 ML10 HA5 PNC 27 PNC 27 PI5 PI10 P20
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
DSIP Thymosin Alpha-1 DS5 DS15 TA5 TA10 SS-31 MT1 2S10 2S50 MT-2 ML10 High quality source factory
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
SK5 DS LC120 SuperHumanBlend HC RT60 DS5 XA10 TA5 TR30 RT15 5AD
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
TR50 TR60 RT5 RT10 NJ500 NJ1000 GT600(Brand) GT1500 CGL5 CGL10 cagrilintide CAS868844-74-0
Pharmaceutical Grade / 99%
$1/G FOB
-
